PPTA has developed a system that we believe is the best way to present the distribution of the core plasma protein therapies in the U.S. Based on extensive research into a new system in consultation with a third party, it was determined that the aggregate distribution data is the most reliable and useful data points (as opposed to inventory) in attempting to determine the status of total U.S. supply of plasma protein therapies. Providing actual distribution data is the best measure of the status of industry wide availability of plasma protein therapies.

The new PPTA web-based information system provides monthly charts for each of the five product groups covered by the Data Collection Program:

Albumin 5%
Albumin 25%
Immune Globulin (Ig)
Plasma-derived Factor VIII
Recombinant Factor VIII

The charts can be accessed by clicking on the link to the product category of your choice in the box above. Each chart shows a 12 month snapshot consisting of two lines: one plotting the data points for the monthly distribution volume and another to show the data points for the previous 12 month average distribution volume on a rolling basis.